FTSE Mondo Visione Exchanges Index:
News Centre
-
United Wholesale Mortgage Selects ICE Mortgage Technology To Power In-House Servicing Strategy
Date 30/04/2025
- Nation’s largest mortgage lender selects ICE Mortgage Technology’s MSP®to provide world-class servicing support that fuels recapture and referral business for brokers
-
NSE Indices Index Dashboard For The Month Ended April 2025
Date 30/04/2025
Click here to download the 'Index Dashboard' for the month ended April 2025.
-
U.S. Department Of The Treasury Quarterly Refunding Statement Of Acting Assistant Secretary For Financial Markets Brian Smith
Date 30/04/2025
The U.S. Department of the Treasury is offering $125 billion of Treasury securities to refund approximately $94.2 billion of privately-held Treasury notes maturing on May 15, 2025. This issuance will raise new cash from private investors of approximately $30.8 billion.
-
Bank Of England's Renewed RTGS Service Goes Live
Date 30/04/2025
On 28 April, our renewed RTGS service – known as RT2 – went live. RT2 will support our strategic objectives for RTGS and CHAPS and act as an open platform for change and innovation, driving improvement in wholesale settlement efficiency and facilitating greater competition.
-
HKEX: Report On Initial Public Offering Applications, Delisting And Suspensions (April 2025)
Date 30/04/2025
This monthly report provides key statistics relating to the various stages in discharging our regulatory oversight duties during the reporting period. The information for the reporting period covers, among others, the number of applications processed and their current status, the number of comment letters and guidance issued to new/ potential new listing applicants and their advisers with the corresponding processing time, the number of rejection and return of listing applications, as well as the number of delisted and suspended companies.
-
TMX Group Ushers In A New Era In Canada’s Markets With Post Trade Modernization - CDS, Canada's Equities And Fixed Income Clearinghouse, Introduces Major Upgrades To Critical Infrastructure Designed To Better Serve Global Client Base
Date 30/04/2025
The Canadian Depository for Securities Limited (CDS), a wholly-owned subsidiary of TMX Group Limited (TMX Group), this week implemented upgrades to CDS's foundational clearing technology, designed under its post trade modernization initiative (PTM), which includes the replacement of certain legacy systems related to clearing and settlement, as well as depository and entitlement payments.
-
ESMA Publishes The Annual Transparency Calculations For Non-Equity Instruments And Bond Liquidity Data
Date 30/04/2025
The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has published the results of the annual transparency calculations for non-equity instruments and new quarterly liquidity assessment of bonds under MiFID II and MiFIR.
-
Poll Results Of 2025 Annual General Meeting, Re-Appointment Of Chairman And New Appointments To HKEX Board
Date 30/04/2025
Hong Kong Exchanges and Clearing Limited (HKEX) today (Wednesday) hosted its 2025 Annual General Meeting (AGM). All proposed resolutions as set out in the notice of AGM dated 20 March 2025 were passed. Please refer to the regulatory announcement issued today for the results by resolution.
-
Allica Bank Launches Long-Term Sub Hire Product And Celebrates Record-Breaking Month In Asset Finance
Date 30/04/2025
- Long-term sub hire now available with a hire period of up to 36 months
- New product benefits from Allica’s high speed application process
- Product launch follows record breaking month in asset finance for Allica Bank, with £100 million of applications and more than 60% of applications approved
-
Biopharma Venture Financing Declines 20.2% YoY In Q1 2025 Amid Persistent Investor Caution, Reveals GlobalData
Date 30/04/2025
Biopharmaceutical drug company venture financing witnessed a year-on-year (YoY) 20.2% downturn from $8.1 billion during the first quarter (Q1) of 2024 to $6.5 billion in Q1 2025. This suggests that the biopharmaceutical venture financing environment remains challenging, mirroring a similar downturn seen in 2022 and 2023, with investors continuing to favor later-stage companies with clinical data, says GlobalData, a leading data and analytics company.
